S1PR4 and neoplasm: Depletion of S1PR4 potentiated the effect of anti-PD-1 immunotherapy in a synergistic manner resulting in reduced tumor growth and increased survival rate of tumor-bearing S1PR4-/- compared to WT mice [17].